MAPK8IP2 and colorectal carcinoma: External dataset validation and functional experiments confirmed that silencing BAMBI, MAPK8IP2, or BMP7 directly altered oxaliplatin sensitivity in CRC cell lines, supporting their potential as predictive biomarkers.